Taken together, these results suggest that FXR may serve as a key transcriptional regulator of cell proliferation in HCC by stimulating SOCS3 expression, and FXR-SOCS3 pathway may be a novel target for the treatment/prevention of HCC. Here, NR1H4 is linked to hepatocellular carcinoma.